SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001714899-22-000043
Filing Date
2022-02-17
Accepted
2022-02-17 20:25:24
Documents
2
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_164514750112269.html 5  
1 FORM 5 wf-form5_164514750112269.xml 5 6442
2 POWER OF ATTORNEY FOR: /S/ TYLER NIELSEN, BY POWER OF ATTORNEY poa.htm EX-24 2179
  Complete submission text file 0001714899-22-000043.txt   9986
Mailing Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080
Business Address
Tessier-Lavigne Marc (Reporting) CIK: 0001437435 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38311 | Film No.: 22650474

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)